Semler Scientific Inc

NASDAQ:SMLRUnited States

Semler Scientific, Inc. provides technology solutions to healthcare providers. The Company develops, manufactures, and markets products and services that assist its customers in evaluating and treating chronic diseases. Its vascular testing product, QuantaFlo, measures arterial blood flow in the extremities to aid in the diagnosis of peripheral arterial disease (PAD). QuantaFlo is a four-minute in-office blood flow test. Healthcare providers can use blood flow measurements as part of their examinations of a patient's vascular condition, including assessments of patients who have vascular disease. It also has a distribution arrangement for the United States, including Puerto Rico, to distribute Insulin Insights, a software solution designed to provide insulin dosing recommendations to clinicians for the adjustment and maintenance of blood. The Company's customers for QuantaFlo include insurance plans, physician groups, and risk assessment groups.

Contact Information

Headquarters

2340-2348 Walsh Avenue, Suite 2344SANTA CLARA, CA, United States 95051

Phone

408-627-4557

Fax

302-636-5454

Executives

Chief Executive Officer, Director

Douglas Murphy-Chutorian

Principal Financial Officer, Senior Vice President - Finance and Accounting

Andrew Weinstein

Vice President - Finance

Daniel Conger

Independent Director

Arthur Leibowitz

Independent Director

Daniel Messina